Okeke IN, Fayinka ST, Lamikanra A: Antibiotic resistance trends in Escherichia coli from apparently healthy Nigerian students (1986-1998). Emerg Infect Dis. 2000, 6 (4): 393-396. 10.3201/eid0604.000413.
Article
PubMed
CAS
PubMed Central
Google Scholar
Mendez Arancibia E, Pitart C, Ruiz J, Marco F, Gascon J, Vila J: Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea. J Antimicrob Chemother. 2009, 64 (2): 343-347. 10.1093/jac/dkp178.
Article
PubMed
CAS
Google Scholar
Okeke IN, Lamikanra A, Czeczulin J, Dubovsky F, Kaper JB, Nataro JP: Heterogeneous virulence of enteroaggregative Escherchia coli strains isolated from children in Southwest Nigeria. J Infect Dis. 2000, 181: 252-260. 10.1086/315204.
Article
PubMed
CAS
Google Scholar
Okeke IN, Steinruck H, Kanack KJ, Elliott SJ, Sundstrom L, Kaper JB, Lamikanra A: Antibiotic-resistant cell-detaching Escherichia coli strains from Nigerian children. J Clin Microbiol. 2002, 40 (1): 301-305. 10.1128/JCM.40.1.301-305.2002.
Article
PubMed
PubMed Central
Google Scholar
Soge OO, Adeniyi BA, Roberts MC: New antibiotic resistance genes associated with CTX-M plasmids from uropathogenic Nigerian Klebsiella pneumoniae. J Antimicrob Chemother. 2006, 58 (5): 1048-1053. 10.1093/jac/dkl370.
Article
PubMed
CAS
Google Scholar
Nabeth P, Perrier-Gros-Claude J-D, Juergens-Behr A, Dromigny J-A: In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal. Scand J Infect Dis. 2005, 37 (6): 497-499. 10.1080/00365540510038956.
Article
PubMed
CAS
Google Scholar
Newman MJ, Frimpong E, Asamoah-Adu A, Sampane-Donkor E, Opintan JA: Resistance to antimicrobial drugs in Ghana. The Ghanaian-Dutch Collaboration for Health Research and Development. 2004
Google Scholar
Nys S, Okeke IN, Kariuki S, Dinant GJ, Driessen C, Stobberingh EE: Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother. 2004, 54 (5): 952-955. 10.1093/jac/dkh448.
Article
PubMed
CAS
Google Scholar
Hawkey PM: Mechanisms of quinolone action and microbial response. J Antimicrob Chemother. 2003, 29-35. 10.1093/jac/dkg207. 51 Suppl 1
Hopkins KL, Davies RH, Threlfall EJ: Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents. 2005, 25 (5): 358-373. 10.1016/j.ijantimicag.2005.02.006.
Article
PubMed
CAS
Google Scholar
Hooper DC: Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis. 2001, 32 (Suppl 1): S9-S15. 10.1086/319370.
Article
PubMed
CAS
Google Scholar
Wang H, Dzink-Fox JL, Chen M, Levy SB: Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother. 2001, 45 (5): 1515-1521. 10.1128/AAC.45.5.1515-1521.2001.
Article
PubMed
CAS
PubMed Central
Google Scholar
Tran JH, Jacoby GA: Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA. 2002, 99 (8): 5638-5642. 10.1073/pnas.082092899.
Article
PubMed
CAS
PubMed Central
Google Scholar
Hansen LH, Jensen LB, Sørensen HI, Sørensen SJ: Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J Antimicrob Chemother. 2007, 60 (1): 145-147. 10.1093/jac/dkm167.
Article
PubMed
CAS
Google Scholar
Yamane K, Wachino J-i, Suzuki S, Kimura K, Shibata N, Kato H, Shibayama K, Konda T, Arakawa Y: New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 2007, 51 (9): 3354-3360. 10.1128/AAC.00339-07.
Article
PubMed
CAS
PubMed Central
Google Scholar
Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A: Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009, 22 (4): 664-689. 10.1128/CMR.00016-09.
Article
PubMed
CAS
PubMed Central
Google Scholar
Morgan-Linnell SK, Zechiedrich L: Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 2007, 51 (11): 4205-4208. 10.1128/AAC.00647-07.
Article
PubMed
CAS
PubMed Central
Google Scholar
Eaves DJ, Randall L, Gray DT, Buckley A, Woodward MJ, White AP, Piddock LJV: Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother. 2004, 48 (10): 4012-4015. 10.1128/AAC.48.10.4012-4015.2004.
Article
PubMed
CAS
PubMed Central
Google Scholar
Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, et al: Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol. 2006, 60 (5): 1136-1151. 10.1111/j.1365-2958.2006.05172.x.
Article
PubMed
CAS
PubMed Central
Google Scholar
Livermore DM: Has the era of untreatable infections arrived?. J Antimicrob Chemother. 2009, 64 (Suppl 1): i29-36. 10.1093/jac/dkp255.
Article
PubMed
CAS
Google Scholar
Opintan JA, Newman MJ, Nsiah-Poodoh OA, Okeke IN: Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element. J Antimicrob Chemother. 2008, 62 (5): 929-933. 10.1093/jac/dkn334.
Article
PubMed
CAS
PubMed Central
Google Scholar
Robinson DA, Falush D, Feil EJ: Bacterial population genetics in infectious disease. 2010, Hoboken, N.J.: J. Wiley
Chapter
Google Scholar
Uchida Y, Mochimaru T, Morokuma Y, Kiyosuke M, Fujise M, Eto F, Eriguchi Y, Nagasaki Y, Shimono N, Kang D: Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors. Int J Antimicrob Ag. 2010, 35 (5): 444-450. 10.1016/j.ijantimicag.2009.12.012.
Article
CAS
Google Scholar
Johnson James R, Kuskowski Michael A, Owens K, Gajewski A, Winokur Patricia L: Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis. 2003, 188 (5): 759-768. 10.1086/377455.
Article
PubMed
CAS
Google Scholar
Moreno E, Prats G, Sabate M, Perez T, Johnson JR, Andreu A: Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother. 2006, 57 (2): 204-211. 10.1093/jac/dki468.
Article
PubMed
CAS
Google Scholar
Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG: Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother. 2009, 53 (7): 2733-2739. 10.1128/AAC.00297-09.
Article
PubMed
CAS
PubMed Central
Google Scholar
Grude N, Strand L, Mykland H, Nowrouzian FL, Nyhus J, Jenkins A, Kristiansen BE: Fluoroquinolone-resistant uropathogenic Escherichia coli in Norway: evidence of clonal spread. Clin Microbiol Infect. 2008, 14 (5): 498-500. 10.1111/j.1469-0691.2008.01952.x.
Article
PubMed
CAS
Google Scholar
Boyd L, Atmar R, Randall G, Hamill R, Steffen D, Zechiedrich L: Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infectious Diseases. 2008, 8 (1): 4-10.1186/1471-2334-8-4.
Article
PubMed
PubMed Central
Google Scholar
Davidson RJ, Davis I, Willey BM, Rizg K, Bolotin S, Porter V, Polsky J, Daneman N, McGeer A, Yang P, et al: Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America. PLoS ONE. 2008, 3 (7): e2727-10.1371/journal.pone.0002727.
Article
PubMed
PubMed Central
Google Scholar
van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M: Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008, 14 (11): 1722-1730. 10.3201/eid1411.070467.
Article
PubMed
PubMed Central
Google Scholar
Gottesman Bat S, Carmeli Y, Shitrit P, Chowers M: Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis. 2009, 49 (6): 869-875.
Article
Google Scholar
Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG: Bad bugs need drugs: An update on the development pipeline from the antimicrobial availability task force of the Infectious Diseases Society of America. Clin Infect Dis. 2006, 42 (5): 657-668. 10.1086/499819.
Article
PubMed
Google Scholar
Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, Pablos-Mendez A, Laxminarayan R: Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005, 5 (9): 568-580. 10.1016/S1473-3099(05)70217-6.
Article
PubMed
Google Scholar
Okeke IN, Aboderin AO, Byarugaba DK, Ojo O, Opintan JA: Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis. 2007, 13 (11): 1640-1646.
Article
PubMed
PubMed Central
Google Scholar
Nugent R, Okeke IN: When medicines fail: recommendations for curbing antibiotic resistance. J Infect Dev Ctries. 2010, 4 (6): 355-356.
PubMed
Google Scholar
Lane DJ: 16S/23 S rRNA sequencing. Nucleic Acid Techniques in Bacterial Systematics. Edited by: Stackebrandt E, Goodfellow M. 1991, New York: John Wiley and Sons, 115-175.
Google Scholar
NCCLS: Performance standards for antimicrobial disk susceptibility tests, 8th Edition; Approved standard. 2003, Villanova, PA: National Committee for Clinical Laboratory Standards, 130-
Google Scholar
O'Brien TF, Stelling JM: WHONET: an information system for monitoring antimicrobial resistance. Emerg Infect Dis. 1995, 1 (2): 66-
Article
PubMed
PubMed Central
Google Scholar
CLSI: Methods for dilution antimicrobial susceptiblity tests for bacteria that grow aerobically, 7th Edition; Approved standard. 2006, Wayne, PA: Clinical and Laboratory Standards Institute
Google Scholar
Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, et al: The complete genome sequence of Escherichia coli K-12. Science. 1997, 277 (5331): 1453-1474. 10.1126/science.277.5331.1453.
Article
PubMed
CAS
Google Scholar
Liu J-H, Deng Y-T, Zeng Z-L, Gao J-H, Chen L, Arakawa Y, Chen Z-L: Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16 S rRNA methylase RmtB-producing Escherichia coli isolates from pigs. Antimicrob Agents Chemother. 2008, 52 (8): 2992-2993. 10.1128/AAC.01686-07.
Article
PubMed
CAS
PubMed Central
Google Scholar
Wu J-J, Ko W-C, Tsai S-H, Yan J-J: Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother. 2007, 51 (4): 1223-1227. 10.1128/AAC.01195-06.
Article
PubMed
CAS
PubMed Central
Google Scholar
Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S, Kawada Y: Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae. J Antimicrob Chemother. 1997, 40 (4): 543-549. 10.1093/jac/40.4.543.
Article
PubMed
CAS
Google Scholar